Product Details

Triumeq

Dolutegravir (Dolutegravir Sodium); Abacavir; Lamivudine
50 mg; 600 mg; 300 mg
Tablet

ROA

Oral

Applicant Name

GlaxoSmithKline Pharmaceutical Nig. PLC (GSK)

NRN

B4-8285

Status

Inactive


Composition

 

ATC Code

J05AR13  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

 

Product Description

Film-coated tablet Each tablet contains: Dolutegravir (as sodium) 50 mg, Abacavir (as sulfate) 600 mg, and Lamivudine 300 mg

Manufacturer Name

Glaxo Operations UK Limited

Manufacturer Country

UNITED KINGDOM  

Approval Date

2018-02-27  

Expiry Date

2023-02-26